Korea's First Dual-Energy Heart Ablation: Samsung Medical Center Ushers in New Era

Samsung Medical Center has made medical history in South Korea by performing the nation's first dual-energy ablation for atrial fibrillation, merging pulsed-field and radiofrequency techniques within a single catheter. This breakthrough procedure, announced on October 7, 2026, promises more precise and safer treatments by allowing doctors to switch energy types during the procedure, tailoring care to each patient's unique heart condition and the specific area being treated. This innovative approach directly addresses the limitations of traditional single-energy ablations, which often struggle to balance effectiveness with minimizing damage to nearby delicate tissues like the esophagus or phrenic nerve. While pulsed-field ablation (PFA) is considered a next-generation, non-thermal method for its tissue-specific cell death through electroporation, radiofrequency ablation (RFA) remains crucial for effectively treating thicker heart muscle areas. By combining both, hospitals like Samsung Medical Center can now offer a 'best of both worlds' solution, enhancing both the safety and success rates for complex cardiac arrhythmia. Leading medical technology companies, such as Medtronic, are also developing similar dual-energy systems, indicating a significant global trend in this specialized field. The success of this pioneering procedure at Samsung Medical Center could accelerate the wider adoption of dual-energy ablation technology across South Korea and potentially set a new standard for cardiac care worldwide. Electrophysiology specialists will closely monitor patient outcomes, and further research will likely explore its application for other types of arrhythmias and even broader medical uses. This development signals a shift towards highly individualized and adaptive treatment strategies, promising better long-term results and fewer complications for patients battling irregular heartbeats.